Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2012

Dec 19, 2012

32939_dirs_2012-12-19_410c83bf-f3ba-4f72-8166-ff4ff5597db9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2012-12-17

Reporting Person: Bourne George W. IV (SVP and CT&OO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-17 Common Stock A 2000 Acquired 12000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-17 Non-Qualified Stock Option (right to buy) $10.87 A 5000 Acquired 2019-12-17 Common Stock (5000) Direct

Footnotes

F1: The acquisition of 2,000 shares of common stock represents 2,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 12/17/2013.

F2: Options for 25% of the shares are each exercisable on 12/17/2013, 12/17/2014, 12/17/2015 and 12/17/2016, respectively.